Cargando…

Short Term Effects of Topical Cyclosporine and Viscoelastic on the Ocular Surfaces in Patients with Dry Eye

PURPOSE: To compare the short term effects of topical 0.05% cyclosporine (CsA) and a mixture of 0.08% chondroitin sulfate and 0.06% sodium hyaluronate (CS-HA) on dry eye ocular surfaces. METHODS: 36 patients with moderate to severe dry eye (5 mm/5 min or less with Schirmer's test or tear break...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Jun Woong, Lee, Hyun-Joo, Shin, Ki Chul, Wee, Won Ryang, Lee, Jin Hak, Kim, Mee Kum
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629882/ https://www.ncbi.nlm.nih.gov/pubmed/18063881 http://dx.doi.org/10.3341/kjo.2007.21.4.189

Ejemplares similares

Preliminary Effects of Oral Uridine on the Ocular Surface in Dry Eye Patients
por: Chang, Ki Cheol, et al.
Publicado: (2009)

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)

The Role of Cyclosporine and Mycophenolate in an Orthotopic Porcine-to-Rat Corneal Xenotransplantation
por: Lee, Hyeon Il, et al.
Publicado: (2008)

The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
por: Chung, Yeon Woong, et al.
Publicado: (2013)

Interleukin-17 in Various Ocular Surface Inflammatory Diseases
por: Kang, Min Ho, et al.
Publicado: (2011)

Intraocular Lens Power Calculation Using IOLMaster and Various Formulas in Short Eyes
por: Roh, Young Rae, et al.
Publicado: (2011)

Investigating the Relationship between Serum Interleukin-17 Levels and Systemic Immune-Mediated Disease in Patients with Dry Eye Syndrome
por: Oh, Joo Youn, et al.
Publicado: (2011)

Evaluation of Corneal Biomechanical Properties Following Penetrating Keratoplasty Using the Ocular Response Analyzer
por: Shin, Joo Young, et al.
Publicado: (2010)

Short-term Efficacy of Topical Immunosuppressive Agents on the Survival of Cultivated Allo-Conjunctival Equivalents
por: Shin, Young Joo, et al.
Publicado: (2008)

Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study
por: Singla, Shaveta, et al.
Publicado: (2019)

Sex differences in the effect of aging on dry eye disease
por: Ahn, Jong Ho, et al.
Publicado: (2017)

A Case of Cataract Surgery without Pupillary Device in the Eye with Iridoschisis
por: Lee, Eun Ji, et al.
Publicado: (2008)

The Short Term Effects of a Single Limbal Relaxing Incision Combined with Clear Corneal Incision
por: Kim, Dong Hyun, et al.
Publicado: (2010)

Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
por: Chan, Yuan-Hsi, et al.
Publicado: (2023)

Cyclosporine Amicellar delivery system for dry eyes
por: Kang, Han, et al.
Publicado: (2016)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2019)

Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren’s Syndrome: a Double-Blind Randomized Control Study
por: Yoon, Chang Ho, et al.
Publicado: (2016)

Topical Cyclosporine A for Treatment of Dry Eye Due to Chronic Mustard Gas Injury
por: Jadidi, Khosrow, et al.
Publicado: (2014)

Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
por: Kanellopoulos, Anastasios John
Publicado: (2019)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
por: Matossian, Cynthia, et al.
Publicado: (2021)

Relationship between ocular surface temperature and 0.1% cyclosporine a in dry eye syndrome with meibomian gland dysfunction
por: Lee, Donghun, et al.
Publicado: (2023)

Comparison of Consecutive Therapeutic Effects of Nanoemulsion and Emulsion Cyclosporin in Dry Eye Patients after Short-Term Treatment with Topical Fluorometholone
por: Choi, Yeon Sun, et al.
Publicado: (2022)

Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2020)

Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
por: Mullick, Ritika, et al.
Publicado: (2021)

Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease
por: Othman, Tageldin M., et al.
Publicado: (2018)

Effect of IRT5 probiotics on dry eye in the experimental dry eye mouse model
por: Moon, Jayoon, et al.
Publicado: (2020)

Treatment of chronic dry eye: focus on cyclosporine
por: Kymionis, George D, et al.
Publicado: (2008)

In Situ Peripheral Iridoplasty in Phakic Eyes for the Treatment of Symptomatic Peripheral Iridotomy
por: Jung, Eun Hye, et al.
Publicado: (2014)

Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane
por: Kim, Seonghwan, et al.
Publicado: (2017)

Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease
por: Priani, Desti, et al.
Publicado: (2023)

An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease
por: Tuan, Hsin-I, et al.
Publicado: (2020)

Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
por: Pisella, Pierre-Jean, et al.
Publicado: (2018)

Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
por: So, Ha Rim, et al.
Publicado: (2023)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
por: Schultz, Clyde
Publicado: (2014)

Can Gut Microbiota Affect Dry Eye Syndrome?
por: Moon, Jayoon, et al.
Publicado: (2020)

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
por: Ryu, Kyung Jae, et al.
Publicado: (2021)

Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren’s syndrome
por: Kim, Kyeong Hwan, et al.
Publicado: (2017)

Clinical Features, Predisposing Factors, and Treatment Outcomes of Scleritis in the Korean Population
por: Ahn, Seong Joon, et al.
Publicado: (2010)

Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model
por: Lin, Xiang, et al.
Publicado: (2020)

An Investigation Comparing the Efficacy of Topical Ocular Application of Tacrolimus and Cyclosporine in Dogs
por: Hendrix, Diane V . H., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vir1hug81qhjlrk7l0q4ps6q9o